Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004500 |
---|---|
Receipt number | R000004940 |
Scientific Title | phase 2 trial of panitumumab and irinotecan in previously oxaliplatin and irinotecan refractory patients with colorectal cancer |
Date of disclosure of the study information | 2010/11/02 |
Last modified on | 2016/11/08 09:48:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/11/02 20:23:55 | ||
2 | Update | 2012/12/03 11:46:38 | Last name of lead principal investigator Last name of lead principal investigator Name of person sending information Name of person sending information Post marketing survey by drug manufacture etc., specified by Japanese law. Organization2 Address2 Tel2 Email2 |
|
3 | Update | 2016/11/08 09:47:46 | Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications Results Results |
|
4 | Update | 2016/11/08 09:48:37 | Recruitment status Publication of results |